X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare with AANJANEYA LIFECARE - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs DR. DATSONS LABS - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES DR. DATSONS LABS ALKEM LABORATORIES/
DR. DATSONS LABS
 
P/E (TTM) x - -10.9 - View Chart
P/BV x 6.1 0.2 3,784.4% View Chart
Dividend Yield % 0.7 0.0 -  

Financials

 ALKEM LABORATORIES   DR. DATSONS LABS
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-16
DR. DATSONS LABS
Mar-14
ALKEM LABORATORIES/
DR. DATSONS LABS
5-Yr Chart
Click to enlarge
High Rs1,589126 1,265.1%   
Low Rs1,23231 3,987.1%   
Sales per share (Unadj.) Rs417.5133.0 313.9%  
Earnings per share (Unadj.) Rs56.30.2 37,131.3%  
Cash flow per share (Unadj.) Rs64.76.6 979.3%  
Dividends per share (Unadj.) Rs12.700-  
Dividend yield (eoy) %0.90-  
Book value per share (Unadj.) Rs292.9128.8 227.5%  
Shares outstanding (eoy) m119.5731.66 377.7%   
Bonus/Rights/Conversions -FCCB-  
Price / Sales ratio x3.40.6 574.2%   
Avg P/E ratio x25.1516.1 4.9%  
P/CF ratio (eoy) x21.811.8 184.1%  
Price / Book Value ratio x4.80.6 792.5%  
Dividend payout %22.60-   
Avg Mkt Cap Rs m168,6532,477 6,807.7%   
No. of employees `000NANA-   
Total wages/salary Rs m9,17156 16,377.3%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m49,9154,211 1,185.5%  
Other income Rs m1,64579 2,090.3%   
Total revenues Rs m51,5614,289 1,202.1%   
Gross profit Rs m8,482569 1,491.8%  
Depreciation Rs m1,006204 492.1%   
Interest Rs m671430 155.9%   
Profit before tax Rs m8,45113 66,543.3%   
Minority Interest Rs m-1140-   
Prior Period Items Rs m0-2 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,6066 26,327.9%   
Profit after tax Rs m6,7315 140,233.3%  
Gross profit margin %17.013.5 125.8%  
Effective tax rate %19.048.0 39.6%   
Net profit margin %13.50.1 11,829.1%  
BALANCE SHEET DATA
Current assets Rs m27,0626,852 395.0%   
Current liabilities Rs m15,3246,711 228.3%   
Net working cap to sales %23.53.3 702.2%  
Current ratio x1.81.0 173.0%  
Inventory Days Days67161 41.3%  
Debtors Days Days41318 13.0%  
Net fixed assets Rs m12,6103,673 343.3%   
Share capital Rs m239317 75.5%   
"Free" reserves Rs m34,4903,761 917.0%   
Net worth Rs m35,0274,078 859.0%   
Long term debt Rs m1,2121,671 72.5%   
Total assets Rs m54,38712,633 430.5%  
Interest coverage x13.61.0 1,321.2%   
Debt to equity ratio x00.4 8.4%  
Sales to assets ratio x0.90.3 275.4%   
Return on assets %13.63.4 395.2%  
Return on equity %19.20.1 16,324.8%  
Return on capital %24.97.7 323.9%  
Exports to sales %12.922.9 56.5%   
Imports to sales %3.114.3 21.6%   
Exports (fob) Rs m6,461964 670.2%   
Imports (cif) Rs m1,540602 255.9%   
Fx inflow Rs m6,563964 680.8%   
Fx outflow Rs m3,012607 496.1%   
Net fx Rs m3,552357 995.1%   
CASH FLOW
From Operations Rs m7,2591,345 539.7%  
From Investments Rs m1,864-2,256 -82.6%  
From Financial Activity Rs m-9,273-1,200 772.9%  
Net Cashflow Rs m-150-2,111 7.1%  

Share Holding

Indian Promoters % 66.9 4.5 1,476.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 33.1 0.0 -  
FIIs % 0.0 1.4 -  
ADR/GDR % 0.0 0.0 -  
Free float % 0.0 94.1 -  
Shareholders   68,381 20,807 328.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   FULFORD INDIA  SUVEN LIFE  CIPLA  WOCKHARDT LTD.  VENUS REMEDIES  

Compare ALKEM LABORATORIES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Continue Momentum; Realty Sector Up 2.7%(11:30 am)

After opening the day higher, stock markets in India have continued their momentum. Sectoral indices are trading on a positive note with stocks in the realty sector.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Aug 23, 2017 12:28 PM

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES - SUVEN LIFE COMPARISON

COMPARE ALKEM LABORATORIES WITH

MARKET STATS